Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Predicting The User Fee Reauthorization Schedule
Feb 04 2020
•
By
Derrick Gingery
and M. Nielsen Hobbs
Industry and US FDA officials likely will meet for months to hammer out the agreements needed to reauthorize the three user fee programs. • Source: Pink Sheet Illustration
More from User Fees
More from Pathways & Standards